We are thrilled to announce that the US @FDA has granted De Novo marketing authorization for our AI-powered SCANLY Home OCT, the first-ever home retinal imaging service to monitor wet AMD, the leading cause of blindness for older patients. notalvision.info/Introducing… #homeOCT #AI

Congrats to Dr. Jordana Fein & Retina Group of Washington on a wet AMD catch with ForeseeHome! After 10+ years of consistent home monitoring, a ForeseeHome alert led to a wet AMD diagnosis while patient maintained 20/25 vision. A decade of monitoring making a difference!

Discover Home OCT and Medicare-covered AMD monitoring at AAO 2026!  Visit Notal Vision at AAO 2026 in New Orleans, Booth #1500. Discuss clinical cases, practice workflow implementation, and physician reimbursement opportunities. #AAO2026 #Retina #HomeOCT #AMD #Ophthalmology

🏠 Home OCT in the real world At Retina Society this year, Dr. Miguel Busquets from Cincinnati Eye Institute presented a compelling case of a patient being managed with SCANLY Home OCT monitoring in a real-world setting—one of the first cases of its kind.

Congrats to Dr. Eric Weldy & Piedmont Retina Specialists on a ForeseeHome catch! 👏 Referred in Feb with 20/40 VA, the patient alerted just months later and was diagnosed with wet AMD at 20/20 VA—potentially months before their next scheduled exam. #digitalhealth #AMD #Retina

We’re excited to join the optometry community at the American Academy of Optometry meeting! Nishant Mohan, PhD, from Notal Vision will be attending the meeting. If you’ll be there, be sure to say hello! #AAOptometry #Optometry #Retina #DigitalHealth #RemoteMonitoring #NotalVision

Congrats to Jay Haynie, OD & the Sound Retina team on a ForeseeHome catch. Referred in Jan. 2026 at 20/40, the patient alerted in April and was diagnosed with wet AMD at 20/50, potentially months before their next routine visit. #AMD #remotemonitoring #AI #retina

Intriguing and thoughtful discussion on role home OCT based monitoring can play in management of wet-AMD, the leading cause of blindness in the developed world. Great insights by Dr. Christina Weng, Dr. Noam Rudnick and Dr. Christina Flaxel. notalvision.info/4xlcJka

What happens between the office visits for a neovascular AMD patient on long-acting treatments? Home OCT shows quick resolution of intraretinal fluid after refill, complete absence of macular fluid for several months. 𝘏𝘰𝘭𝘦𝘬𝘢𝘮𝘱, 𝘕𝘢𝘯𝘤𝘺 𝘔 𝘦𝘵 𝘢𝘭. (2024): 1714.

Congratulations to Dr, Michael Grassi & Grassi Retina on a ForeseeHome catch! After an alert, patient was seen just 2 days later and diagnosed with wet AMD while vision was still 20/25-2. Proud to support monitoring between visits. #AMD #remotemonitoring #digitalhealth #AI

Healio’s coverage of Home OCT results presented at the American Society of Retina Specialists Annual Meeting. See the insightful findings presented by Prof. Anat Loewenstein. notalvision.info/4hDlGQP

Dr. Anat Loewenstein @anatlow presented results from her study evaluating longitudinal AI-based Home OCT data against annotations from expert graders. The discussion reflected growing interest in Home OCT monitoring, particularly in the era of longer-acting treatments!

Congratulations to Whitney Boling, MD and Boling Vision Center on an early wet AMD catch with ForeseeHome. Referred at 20/20, the patient was diagnosed just days after an alert with vision still at 20/25. #MacularDegeneration #Retina #eyesoninnovation #digitalhealth

Longer-lasting retinal therapies are changing care, but between-visit data matters too. New Medicina study shows Home OCT monitoring can help detect nAMD activity before next scheduled visit, giving drs added visibility between appts. notalvision.info/4eCEIoP #Retina #HomeOCT

Congratulations to David Dao, MD and the Elman Retina Group team on a textbook #ForeseeHome catch case. Referred with 20/20 vision. Excellent tester. Alerted in March 2026. Seen, diagnosed with wet AMD, and treated the next day while vision was still 20/30. #AMD #retina

Another great Clinical Trials at the Summit in the books! Prof. Anat Loewenstein delivered an excellent presentation on the future of wet #AMD care, incl. long-acting treatments, home OCT-based monitoring, and the role #homeOCT may play in clinical trials. #CTS2026 #digitalhealth

Great ForeseeHome catch by Henry Bausback, MD and The Eye Associates team. Referred in Apr 2025, this highly consistent tester alerted in Feb 2026. The alert led to wet AMD diagnosis and prompt treatment while vision was still 20/25. #AMD #retina #eyesoninnovation #digitalhealth

Home OCT is more than a device. It is a connected care model supporting wet AMD monitoring between visits. In this Retina Synthesis discussion, Prof. Anat Loewenstein shares why validated AI, patient support, and physician oversight matter. Listen here: notalvision.info/4usGihH

“The home eye exam” is part of the eye care conversation. This article highlights both ForeseeHome and SCANLY Home OCT as examples of how home monitoring can support physicians with information between regularly scheduled office visits. Read more: notalvision.info/3Sfg3h4

Eight years of consistent ForeseeHome testing. One important alert. A 20/20 wet AMD diagnosis. Congratulations to Rahul Komati, MD and the Georgia Retina team on an outstanding catch that highlights the value of long-term monitoring. #maculardegeneration #retina #digitalhealth

A great catch by Scott Prickett and @TheEyeAssociate team with #ForeseeHome. Referred in Nov. 2025 with 20/30 vision, patient alerted in early Feb. 2026. Wet #AMD conversion was diagnosed while vision remained 20/30. Proud to support monitoring patients between visits.